1. Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagenm F, Daumann J (2002) Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or Cannabis? Biol Psychiatry 51:766–769
2. Richardson KA, Hester AK, McLemore GL (2016) Prenatal Cannabis exposure – the “first hit” to the endocannabinoid system. Neurotoxicol Teratol 58:5–14
3. Sauvanier M, Constans J, Skopinski S, Barcat D, Berard A, Parrot F, Guerin V, Vergnes C, Midy D, Baste JC, Conri C (2002) Les Artériopathies des Membres Inférieurs Débutant Avant 50 Ans [Lower limb occlusive Arteriopathy: retrospective analysis of 73 patients with onset before the age of 50 years]. J Mal Vasc 27(2):69–76
4. Brophy S, Calin A (2001) Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 28(10):2283–2288
5. American Psychiatric Association (2013) Cannabis use disorder. Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association